GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inhibrx Biosciences Inc (NAS:INBX) » Definitions » Price-to-Free-Cash-Flow

INBX (Inhibrx Biosciences) Price-to-Free-Cash-Flow : N/A (As of May. 11, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Inhibrx Biosciences Price-to-Free-Cash-Flow?

As of today (2025-05-11), Inhibrx Biosciences's share price is $11.175. Inhibrx Biosciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-13.20. Hence, Inhibrx Biosciences's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Inhibrx Biosciences's Price-to-Free-Cash-Flow or its related term are showing as below:

INBX's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 29.035
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Inhibrx Biosciences's Free Cash Flow per Share for the three months ended in Dec. 2024 was $-2.83. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-13.20.


Inhibrx Biosciences Price-to-Free-Cash-Flow Historical Data

The historical data trend for Inhibrx Biosciences's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inhibrx Biosciences Price-to-Free-Cash-Flow Chart

Inhibrx Biosciences Annual Data
Trend Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
- - -

Inhibrx Biosciences Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Inhibrx Biosciences's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Inhibrx Biosciences's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inhibrx Biosciences's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inhibrx Biosciences's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Inhibrx Biosciences's Price-to-Free-Cash-Flow falls into.


;
;

Inhibrx Biosciences Price-to-Free-Cash-Flow Calculation

Inhibrx Biosciences's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=11.175/-13.2
=N/A

Inhibrx Biosciences's Share Price of today is $11.175.
Inhibrx Biosciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.20.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Inhibrx Biosciences  (NAS:INBX) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Inhibrx Biosciences Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Inhibrx Biosciences's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Inhibrx Biosciences Business Description

Traded in Other Exchanges
N/A
Address
11025 N. Torrey Pines Road, Suite 140, La Jolla, CA, USA, 92037
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.